Symetis Completes Enrollment, Obtains Positive Results

Symetis SA, a private Swiss company developing new transcatheter aortic valve implantation systems, announced Thursday the completion of patient enrollment in its Acurate TAT first-in-man clinical study and positive preliminary results.
One News Page